Diabetes & Endocrinology
391 - 405 of
974 Results
Sort Results:
Commentary:
FDA to Lift Some Avandia (Rosiglitazone) Prescribing/Dispensing Restrictions
January 2014
Article:
More payers are trying to rein in the use of antipsychotics in patients WITHOUT psychotic disorders
December 2013
Article:
Experts will debate whether gliptins (Onglyza, etc) increase cardiovascular risk in patients with type 2 diabetes
November 2013